Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: A 6-year follow up study

BMC Public Health

Volumn 11, Issue , 2011, Pages

  De Fine Olivarius, Niels ^a   Siersma, Volkert ^a   Almind, Gitte Juul ^a   Nielsen, Niels Vesti ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY; VISION TEST; VISUAL ACUITY; VISUAL DISORDER;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; VISION DISORDERS; VISION TESTS; VISUAL ACUITY; YOUNG ADULT;

EID: 79551602708     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-80     Document Type: Article

References (49)

1. What is the prevalence of visual impairment in the general and diabetic populations: are there ethnic and gender differences? LM Hayward ML Burden AC Burden H Blackledge NT Raymond JL Botha WS Karwatowski T Duke YF Chang, Diabet Med 2002 19 27 (Pubitemid 34146634)
2. Diabetes mellitus and visual impairment: national health and nutrition examination survey, 1999-2004. X Zhang EW Gregg YJ Cheng TJ Thompson LS Geiss MR Duenas JB Saaddine, Arch Ophthalmol 2008 126 1421 1427 10.1001/archopht.126.10. 1421 18852421
3. Current trends in newly registered blindness in Denmark. T Rosenberg F Klie, Acta Ophthalmol Scand 1996 74 395 398 10.1111/j.1600-0420.1996.tb00716.x 8883558 (Pubitemid 26319458)
4. Common causes of blindness and visual handicap in the west of Scotland. IM Ghafour D Allan WS Foulds, Br J Ophthalmol 1983 67 209 213 10.1136/bjo.67.4.209 6830738 (Pubitemid 13114741)
5. Causes of blindness and visual impairment in the West of Scotland. MA Bamashmus B Matlhaga GN Dutton, Eye 2004 18 257 261 10.1038/sj.eye.6700606 15004574 (Pubitemid 38455893)
6. The occurrence and causes of registered blindness in diabetes patients in Arhus County, Denmark. P Jeppesen T Bek, Acta Ophthalmol Scand 2004 82 526 530 10.1111/j.1600-0420.2004.00313.x 15453847 (Pubitemid 39386962)
7. Prevalence of blindness and visual impairment in a population of people with diabetes. S Prasad GG Kamath K Jones LG Clearkin RP Phillips, Eye 2001 15 640 643 11702977 (Pubitemid 33014769)
8. Global data on visual impairment in the year 2002. S Resnikoff D Pascolini D Etya'ale I Kocur R Pararajasegaram GP Pokharel SP Mariotti, Bull World Health Organ 2004 82 844 851 15640920 (Pubitemid 39573742)
9. The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population. The Copenhagen City Eye Study. H Buch T Vinding CM La NV Nielsen, Acta Ophthalmol Scand 2001 79 441 449 10.1034/j.1600-0420. 2001.790503.x 11594976 (Pubitemid 32962831)
10. The impact of diabetic retinopathy: perspectives from patient focus groups. KS Coyne MK Margolis T Kennedy-Martin TM Baker R Klein MD Paul DA Revicki, Fam Pract 2004 21 447 453 10.1093/fampra/cmh417 15249536 (Pubitemid 39162015)
11. The influence of diabetic retinopathy on quality of life Interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. A Woodcock C Bradley R Plowright T Ffytche T Kennedy-Martin A Hirsch, Patient Educ Couns 2004 53 365 383 10.1016/j.pec.2003.10.007 15186876 (Pubitemid 38759164)
12. Utility values and diabetic retinopathy. MM Brown GC Brown S Sharma G Shah, Am J Ophthalmol 1999 128 324 330 10.1016/S0002-9394(99)00146-4 10511027 (Pubitemid 29413229)
13. Fear of visual loss in patients with diabetes: results of the Prevalence of Diabetic Eye Disease in Tayside, Scotland (P-DETS) study. R Luckie G Leese R McAlpine CJ MacEwen PS Baines AD Morris JD Ellis, Diabet Med 2007 24 1086 1092 10.1111/j.1464-5491.2007.02180.x 17888131 (Pubitemid 47437873)
14. The incidence of visual impairment and its determinants in the WHO multinational study of vascular disease in diabetes. E Miki M Lu ET Lee H Keen PH Bennett D Russell, Diabetologia 2001 44 31 S36 10.1007/PL00002937 11587048
15. Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycaemic agents and diet regime alone. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. NV Nielsen, Acta Ophthalmol 1984 62 266 273 (Pubitemid 14161441)
16. The Incidence of Vision Loss in A Diabetic Population. SE Moss R Klein BEK Klein, Ophthalmology 1988 95 1340 1348 3265775
17. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects - A 10-year follow-up on evolution, risk factors, and prognostic significance. RM Voutilainen-Kaunisto ME Terasvirta MIJ Uusitupa LK Niskanen, Diabetes Care 2000 23 1672 1678 10.2337/diacare.23.11.1672 11092291
18. Incidence of Cataract-Surgery in the Wisconsin Epidemiologic-Study of Diabetic-Retinopathy. BEK Klein R Klein SE Moss, Am J Ophthalmol 1995 119 295 300 7872389
19. Ten-year incidence of visual loss in a diabetic population. SE Moss R Klein BE Klein, Ophthalmology 1994 101 1061 1070 8008348 (Pubitemid 24183163)
20. The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. R Klein BE Klein SC Jensen SE Moss, Ophthalmology 1994 101 68 76 8302566 (Pubitemid 24044145)
21. Factors Influencing the Development of Visual-Loss in Advanced Diabetic-Retinopathy - Diabetic-Retinopathy Study (Drs) Report No-10. LI Rand GJ Prudhomme F Ederer PL Canner, Invest Ophthalmol Vis Sci 1985 26 983 991 2409053 (Pubitemid 15071719)
22. UKPDS 69. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus. DR Matthews IM Stratton SJ Aldington RR Holman EM Kohner, Arch Ophthalmol 2004 122 1631 1640 10.1001/archopht.122.11.1631 15534123 (Pubitemid 39473407)
23. Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme. M Henricsson M Tyrberg A Heijl L Janzon, Acta Ophthalmol Scand 1996 74 533 538 10.1111/j.1600-0420.1996.tb00729.x 9017036 (Pubitemid 27042672)
24. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. NdF Olivarius H Beck-Nielsen AH Andreasen M Horder PA Pedersen, BMJ 2001 323 970 975 10.1136/bmj.323.7319.970 11679387 (Pubitemid 33016046)
25. Visual acuity measurements. JT Holladay, J Cataract Refract Surg 2004 30 287 290 10.1016/j.jcrs.2004.01.014 15030802 (Pubitemid 38366348)
26. Microalbuminuria as identified by a spot morning urine specimen in non-insulin-treated diabetes: an eight-year follow-up study. OL Beatty CM Ritchie PM Bell DR Hadden L Kennedy AB Atkinson, Diabet Med 1995 12 261 266 10.1111/j.1464-5491.1995.tb00469.x 7758264
27. G Verbeke G Molenberghs, Linear Mixed Models for Longitudinal Data. Springer series in statistics New York: Springer 2000
28. Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. Y Benjamini Y Hochberg, J Roy Stat Soc B 1995 57 289 300
29. Sources of disparity in incidence and prevalence studies of diabetic retinopathy: influence of selective survival on risk factor assessment [letter]. DJ Ballard LJ Melton, Diabetes Care 1986 9 313 315 10.2337/diacare.9.4.334 3731999
30. The effect of optical defocus on the test-retest variability of visual acuity measurements. DA Rosser IE Murdoch SN Cousens, Invest Ophthalmol Vis Sci 2004 45 1076 1079 10.1167/iovs.03-1320 15037571 (Pubitemid 38869010)
31. Standardized measurement of visual acuity. F Ricci C Cedrone L Cerulli, Ophthalmic Epidemiol 1998 5 41 53 10.1076/opep.5.1.41.1499 9575537 (Pubitemid 28190648)
32. Visual impairment in Australia: distance visual acuity, near vision, and visual field findings of the Melbourne Visual Impairment Project. HR Taylor PM Livingston YL Stanislavsky CA McCarty, Am J Ophthalmol 1997 123 328 337 9063242 (Pubitemid 27123039)
33. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. SP Harding DM Broadbent C Neoh MC White J Vora, BMJ 1995 311 1131 1135 7580708
34. Vision loss among diabetics in a group model Health Maintenance Organization (HMO). DS Fong M Sharza W Chen JF Paschal RG Ariyasu PP Lee, Am J Ophthalmol 2002 133 236 241 10.1016/S0002-9394(01)01364-2 11812428 (Pubitemid 34072053)
35. Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. MS Dwyer LJ Melton III DJ Ballard PJ Palumbo JC Trautmann CP Chu, Diabetes Care 1985 8 316 322 10.2337/diacare.8.4.316 4042796 (Pubitemid 15043150)
36. Visual acuity and the causes of visual loss in Australia - The blue mountains eye study. K Attebo P Mitchell W Smith, Ophthalmology 1996 103 357 364 8600410 (Pubitemid 26085889)
37. Inflation in epidemiology: ''The proof and measurement of association between two things'' revisited. GD Smith AN Phillips, BMJ 1996 312 1659 1661 8664725 (Pubitemid 26229461)
38. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early treatment diabetic retinopathy study report #18. MD Davis MR Fisher RE Gangnon F Barton LM Aiello EY Chew FL Ferris GL Knatterud, Invest Ophthalmol Vis Sci 1998 39 233 252 9477980 (Pubitemid 28093859)
39. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. AC Keech P Mitchell PA Summanen J O'Day TM Davis MS Moffitt MR Taskinen RJ Simes D Tse E Williamson, et al. Lancet 2007 370 1687 1697 10.1016/S0140-6736(07)61607-9 17988728 (Pubitemid 350100775)
40. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. IM Stratton EM Kohner SJ Aldington RC Turner RR Holman SE Manley DR Matthews, Diabetologia 2001 44 156 163 10.1007/s001250051594 11270671 (Pubitemid 32156199)
41. Visual impairment in diabetes. R Klein BE Klein SE Moss, Ophthalmology 1984 91 1 9 6709312 (Pubitemid 14184710)
42. The prevalence of blindness and low vision in older onset diabetes mellitus and associated factors: a community-based study. A Idil D Caliskan E Ocaktan, Eur J Ophthalmol 2004 14 298 305 15309974 (Pubitemid 39094808)
43. Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease. E Olafsdottir DK Andersson E Stefansson, Acta Ophthalmol Scand 2007 85 40 45 10.1111/j.1600-0420.2006.00753.x 17244208 (Pubitemid 46140154)
44. Incidence of blindness in southern Germany between 1990 and 1998. C Trautner B Haastert G Giani M Berger, Diabetologia 2001 44 147 150 10.1007/s001250051592 11270669 (Pubitemid 32156197)
45. Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects 10-year follow-up from the diagnosis. RM Voutilainen-Kaunisto ME Terasvirta MIJ Uasitupa LK Niskanen, J Diab Comp 2001 15 24 33 10.1016/S1056-8727(00)00126-4 (Pubitemid 32203888)
46. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. E Agardh CD Agardh C Hansson-Lundblad, Diabet Med 1993 10 555 559 10.1111/j.1464-5491.1993. tb00120.x 8365093 (Pubitemid 23189762)
47. Changes in visual acuity in a population over a 15-year period: The Beaver Dam Eye Study. R Klein BEK Klein KE Lee KJ Cruickshanks RE Gangnon, Am J Ophthalmol 2006 142 539 549 10.1016/j.ajo.2006.06.015 17011842
48. Age-related eye disease, visual impairment, and survival - The Beaver Dam Eye Study. MD Knudtson BEK Klein R Klein, Arch Ophthalmol 2006 124 243 249 10.1001/archopht.124.2.243 16476894 (Pubitemid 43247075)
49. Perceived barriers to diabetic eye care - Qualitative study of patients and physicians. ME Hartnett IJ Key NM Loyacano RL Horswell KB DeSalvo, Arch Ophthalmol 2005 123 387 391 10.1001/archopht.123.3.387 15767483 (Pubitemid 41007586)